In the study of biosignaling pathways, we have previously explored G protein-coupled receptors (GPCRs) and their specific signaling pathways. Recently, our focus has shifted to receptor tyrosine kinases (RTKs), particularly the insulin receptor, which is a type of RTK. Insulin plays a crucial role in glucose metabolism, primarily by decreasing blood glucose levels through various enzymatic pathways, including the involvement of phosphoinositide 3-kinase (PI3K), phosphatidylinositol (3,4,5)-trisphosphate (PIP3), protein kinase B (PKB), and 3-phosphoinositide-dependent protein kinase-1 (PDK1).
Now, we are delving into a new aspect of insulin signaling, where insulin acts as a growth factor. This signaling involves multiple pathways, notably the RAS pathway and the MAPK pathway. The RAS pathway consists of key components such as GRB2, SOS, and RAS, while the MAPK pathway includes RAF1, MEK, and ERK. These pathways are essential for insulin's role in stimulating cell growth and regulating gene expression, in addition to its metabolic functions.
The insulin RTK signaling pathway as a growth factor is initiated by the sequence: GRB2 → SOS → RAS, which subsequently activates the MAPK pathway. In upcoming lessons, we will explore these components in detail, starting with the RAS pathway and then progressing to the MAPK pathway. Understanding these pathways is vital for comprehending how insulin influences both metabolism and cell growth.